Background
In the light of an aging HIV population and improved HIV treatment, Chronic Kidney Disease (CKD) has become a common contributor to morbidity and mortality. Despite that the management of CKD in HIV patients is a growing priority, little is known about the impact of HIV infection on CKD therapy adherence [1] . To investigate adherence to CKD medications and antiretroviral (ARV) medications in patients with co-morbid HIV infection and CKD -in order to identify modifiable predictors of dual adherence, focusing on illness representation and medication beliefs.
Methods
This is a qualitative cross-sectional study that prospectively measures the relationship between disease perceptions and adherence using self-report instruments and the electronic Medication Event Monitoring System (MEMS).
HIV viral loads were used as surrogate markers to validate self-reported adherence to ARV medications. Depression, self-efficacy, alcohol and substance abuse and health literacy were assessed [2] . 20 well-characterized patients with CKD/ESRD and HIV were recruited.Institutional Review Board (IRB) approval was granted. Consent and confidentiality were protected under the Health Insurance Portability and Accountability Act (HIPAA).
Results
(I) Demographics Data: Gender, language, ethnicity, race, education, income marital status and disease precedence did not affect adherence. Higher comorbidity and pill burden correlated with dual non-adherence. (II) Adherence Data: 65% of participants reported dual adherence, 15% reported mono-adherence and 20% reported nonadherence. ARV self-reported adherence correlated with viral load and CD4+ counts. 
Conclusion
The majority of participants perceived CKD to be their main health concern possibly because CKD improvement requires a combination of lifestyle modifications and medication adherence [3] . 
